1. Home
  2. ATHM vs STOK Comparison

ATHM vs STOK Comparison

Compare ATHM & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ATHM

Autohome Inc.

HOLD

Current Price

$22.74

Market Cap

2.1B

Sector

Technology

ML Signal

HOLD

Logo Stoke Therapeutics Inc.

STOK

Stoke Therapeutics Inc.

HOLD

Current Price

$29.48

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ATHM
STOK
Founded
2008
2014
Country
China
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.0B
IPO Year
2013
2019

Fundamental Metrics

Financial Performance
Metric
ATHM
STOK
Price
$22.74
$29.48
Analyst Decision
Hold
Strong Buy
Analyst Count
1
10
Target Price
$28.00
$39.20
AVG Volume (30 Days)
656.0K
753.8K
Earning Date
05-07-2026
05-08-2026
Dividend Yield
9.83%
N/A
EPS Growth
N/A
92.73
EPS
N/A
N/A
Revenue
N/A
$184,420,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.77
$77.49
P/E Ratio
$12.13
N/A
Revenue Growth
N/A
404.50
52 Week Low
$15.57
$12.41
52 Week High
$29.92
$40.22

Technical Indicators

Market Signals
Indicator
ATHM
STOK
Relative Strength Index (RSI) 70.23 43.36
Support Level $21.78 $27.97
Resistance Level $23.96 $33.51
Average True Range (ATR) 0.78 1.61
MACD 0.10 -0.07
Stochastic Oscillator 78.53 33.02

Price Performance

Historical Comparison
ATHM
STOK

About ATHM Autohome Inc.

Founded in 2008 as a media content platform, Autohome is the leading online automobile platform in China, ranking first among automotive service platforms in terms of mobile daily active users, according to QuestMobile. Through its two websites, autohome.com.cn and che168.com, Autohome delivers comprehensive, independent, and interactive content and tools to automobile consumers as well as a full suite of services to automakers and dealers. According to iResearch, the company was the largest online automotive advertising and lead-generation service provider in China's online auto platform media advertising market, in terms of media services and lead-generation revenue.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: